Magellan Diagnostics, Inc. recalls
3 notices naming Magellan Diagnostics, Inc. as the recalling firm, since December 3, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Magellan Diagnostics, Inc.: LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.
Hazard (FDA): In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display…
FDAMedical devices
Magellan Diagnostics, Inc.: (1)(2) LeadCare¿ II Blood Lead Test Kit, (3)LeadCare¿ II 5X Blood Lead Test Kit… and 2 more
Hazard (FDA): Customers reported observing unexpectedly elevated results when using certain third-party micro-collection devices to collect capillary samples for testing with the LeadCare Test Systems. False positive lead results…
FDAMedical devices
Mislabeled
Magellan Diagnostics, Inc.: The LeadCare¿ II Blood Lead Test System relies on electrochemistry and a unique Sensor…
Hazard (FDA): Calibration Buttons being used in the kitting process were incorrectly labeled as Lot 2323M for lot 2333M. The use of mislabeled calibration Button with Lot #2333 can lead to delayed or erroneous high or erroneous low…
FDAMedical devices